COVID-19 – The clinical consequences of social isolation and the relation with sleep bruxism and comorbiditiesOverviews Published on 2021-01-012022-10-28 Journal: Sleep Science [Category] COVID-19, [키워드] adverse effect Anxiety Anxiety obesity association Bruxism cause clinical condition clinical consequence Comorbidity conditions coronavirus COVID-19 COVID-19 disease disease drug Gastroesophageal reflux highly pathogenic Isolation overlapping pandemic patients professional severity Sleep bruxism sleep quality social isolation the disease [DOI] 10.5935/1984-0063.20210004 PMC 바로가기 [Article Type] Overviews
Evaluation of adverse effects with COVID-19 vaccination in PakistanOriginal Article Published on 2021-01-012022-10-29 Journal: Pakistan Journal of Medical Sciences [Category] COVID-19, [키워드] A p-value Administered adverse effect adverse effects age candidate Candidates chill college Comorbidities conducted COVID-19 cross-sectional dentistry determine develop dose Fever flu-like symptom foundation group headache Immunity independent injection linear relationship manifestation mechanism offer Older participant Participants Population receiving reported Side effect Side effects statistically significant Symptoms the vaccine university vaccination Vaccine with COVID-19 [DOI] 10.12669/pjms.37.7.4522 PMC 바로가기 [Article Type] Original Article
CGRP Receptor Antagonism in COVID-19: Potential Cardiopulmonary Adverse EffectsCOVID-19의 CGRP 수용체 길항작용: 잠재적인 심폐 부작용Review Published on 2021-01-012022-09-11 Journal: Trends in molecular medicine [Category] SARS, 신약개발, 치료기술, [키워드] Adverse adverse effect antagonism antagonist Awareness calcitonin calcitonin gene-related peptide Cardiopulmonary CGRP coronavirus Coronavirus 2019 COVID-19 Early detection Effect heart failure hypertension Lung inflammation migraine peptide Potential Prevent protective effect pulmonary hypertension raise receptor receptor antagonists reduce right heart failure right heart failure. Trial US FDA worsening [DOI] 10.1016/j.molmed.2020.10.005 PMC 바로가기 [Article Type] Review
Convalescent Plasma Transfusion for the Treatment of COVID-19—Experience from Poland: A Multicenter StudyArticle Published on 2020-12-242022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] 30-day mortality rate addition Administered adverse effect Clinical improvement comparable convalescent plasma convalescent plasma treatment COVID-19 COVID-19 patient COVID-19 patients database diagnosed with COVID-19 Diagnosis drug duration of hospitalization Effectiveness Efficacy Endpoint endpoints Frequency Hospitalization IMPROVE laboratory parameter mortality rate multicenter study National no significant difference Oxygen therapy Patient patients patients died plasma Remdesivir selected Side effect study population Supportive treatment survival transfusion treating COVID-19 patient Treatment Treatment effectiveness treatment for COVID-19 [DOI] 10.3390/jcm10010028 PMC 바로가기 [Article Type] Article
Gender specific differences in COVID-19 knowledge, behavior and health effects among adolescents and young adults in Uttar Pradesh and Bihar, IndiaResearch Article Published on 2020-12-172022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, SARS, [키워드] Adults adverse effect cohort study COVID-19 COVID-19 knowledge COVID-19 symptom demographics depressive symptom Descriptive analysis disease disease symptom Effect equity Gender Health Health Service Impact India information knowledge less linear lockdown men men and women National outcomes pandemic participant performed Prevent Probability public health question Randomly Regression model resource respondent selected Seven Spread Support symptoms of COVID-19 Variation while women [DOI] 10.1371/journal.pone.0244053 PMC 바로가기 [Article Type] Research Article
COVID-19 as Cause versus Trigger for the Collapse of CapitalismIV. The Political and Economic Determinants of Health Published on 2020-12-092022-10-30 Journal: International journal of health services : plannin [Category] Coronavirus, MERS, SARS, [키워드] adverse effect capitalism cause caused collapse country COVID-19 Depression drastic economics global economy group Health care system help Ideology incarcerated individual Infection lockdowns measure organized pandemic Population populations PROTECT public health quarantine respond School Travel Trigger virus worsening [DOI] 10.1177/0020731420977711 PMC 바로가기 [Article Type] IV. The Political and Economic Determinants of Health
Use of a novel drape ‘tent’ as an infection prevention control measure for mastoid surgeryShort Communication Published on 2020-12-022022-10-30 Journal: The Journal of laryngology and otology [Category] COVID-19, MERS, SARS, [키워드] acute respiratory syndrome adverse effect aerosol aerosol-generating procedure Aerosols Blood Contact coronavirus coronavirus disease Coronavirus-2 COVID-19 droplet Efficiency evaluate had no include Infection prevention limit macroscopic mastoid mastoidectomy Modification objective operating theatre otolaryngology otology pathogen Result risk Spread Support surgeon surgical tissue [DOI] 10.1017/S0022215120002637 PMC 바로가기 [Article Type] Short Communication
Management of immune checkpoint therapy for patients with cancer in the face of COVID-19코로나19에 직면한 암환자의 면역관문치료 관리Article Published on 2020-12-012022-09-11 Journal: Journal for immunotherapy of cancer [Category] SARS, 바이오마커, [키워드] administration adverse effect Antiviral assist Biomarkers caused Chronic diseases clearance coronavirus COVID-19 COVID-19 outbreak death Decision-making ENhance expression immune Immune checkpoint inhibitor Immune checkpoint inhibitors Immunopathogenesis immunopathological damage Immunotherapy in some Inflammation malignant tumor marker medical system MONITOR pandemic Pathogenesis pathogenic Patient Patients with cancer receiving respiratory Respiratory disease respiratory diseases risk SARS-CoV-2 subset T-cell Th1 Th17 therapy Treatment Tumor Usage virus [DOI] 10.1136/jitc-2020-001593 PMC 바로가기 [Article Type] Article
Interferon-inducer antivirals: Potential candidates to combat COVID-19Review Published on 2020-12-012022-10-04 Journal: International immunopharmacology [Category] MERS, SARS, 신약개발, 치료제, [키워드] acute respiratory syndrome adverse effect Antibiotics Antiviral antiviral agent Antiviral effect antivirals approach benefit candidate category Compound compounds coronavirus Coronavirus disease 2019 COVID-19 database Defense disease drug drug candidate Drug repurposing effective evaluated examined help immune response immune system immunosuppressants induce infective interferon lack management mechanism non-steroidal anti-inflammatory drug pandemic Potential risk SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 Side effects signaling pathway Structure synergistic the interferon treating COVID-19 Treatment treatment for COVID-19 triggering Type type I interferon urgency [DOI] 10.1016/j.intimp.2020.107245 PMC 바로가기 [Article Type] Review
Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study코로나바이러스 질병 2019(COVID-19)에 대한 정신 장애 및 하이드록시클로로퀸: VigiBase 연구Article Published on 2020-12-012022-09-11 Journal: Drug safety [Category] 진단, 치료제, [키워드] 95% CI 95% confidence interval Adverse drug reaction Adverse drug reactions adverse effect adverse effects Analysis analyzed calculate Cardiomyopathy cause of death CIs coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 patients database death disorder followed by Health Organization Hydroxychloroquine increased risk indication indications Lopinavir Lopinavir/ritonavir Odds ratio Odds ratios pandemic patients performed Psychiatric psychiatric disorder Psychiatric disorders psychotic disorders raised Remdesivir reported Respiratory failure risk Ritonavir safety profile second Suicide Tocilizumab use of hydroxychloroquine WHO World Health Organization [DOI] 10.1007/s40264-020-01013-3 PMC 바로가기 [Article Type] Article